Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer
Science Advances · 2025
DOI: 10.1126/sciadv.adx0632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Dennis Gong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Health Sciences and Technology, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Proto-Oncogene Proteins p21(ras), Spatial Transcriptomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Analyses of patient-derived cell lines have greatly enhanced discovery of molecular biomarkers and therapeutic targets. However, characterization of cellular morphological properties is limited. We studied cell morphologies of human pancreatic adenocarcinoma (PDAC) cell lines and their associations with drug sensitivity, gene expression, and functional properties. By integrating live cell and spatial messenger RNA imaging, we identified KRAS inhibitor–induced morphological changes specific for drug-resistant cells that correlated with gene expression changes. We then categorized a large panel of patient-derived PDAC cell lines into morphological and organizational subtypes and found differences in gene expression, therapeutic targeting potential, and metastatic proclivity. Patterns of cancer cell organization in human PDAC tissues stratified distinct gene expression signatures with clinical significance. In summary, we highlight the potential of cell morphological information in rapid, cost-effective assays to aid precision oncology efforts leveraging patient-derived in vitro models and tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Health Sciences and Technology, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA.
- Center for Systems Biology, Department of Radiation Oncology, and Krantz Family Center for Cancer Research, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- Bruker Technologies, Inc., Seattle, WA, USA.
ORCID-Profile: Dennis Gong, Rachel Liu, Yi Cui, Jung Woo Bae, Joseph M Beechem, William L Hwang
Förderung
- NCI NIH HHS
Zitieren
APA
Gong, D., Liu, R., Cui, Y., Rhodes, M., Bae, J. W., Beechem, J. M., & Hwang, W. L. (2025). Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer. Science Advances. https://doi.org/10.1126/sciadv.adx0632
Vancouver
Gong D, Liu R, Cui Y, Rhodes M, Bae JW, Beechem JM, et al. Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer. Science Advances. 2025. doi:10.1126/sciadv.adx0632
BibTeX
@article{Gong2025,
author = {Gong, Dennis and Liu, Rachel and Cui, Yi and Rhodes, Michael and Bae, Jung Woo and Beechem, Joseph M and Hwang, William L},
title = {Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx0632}
}
EUVIMED